Klinkert P, van Dijk P J E, Breslau P J
Department of Vascular Surgery, Red Cross Hospital, The Hague, The Netherlands.
Ann Vasc Surg. 2003 Sep;17(5):486-91. doi: 10.1007/s10016-003-0036-8. Epub 2003 Sep 10.
For a femorotibial bypass graft the material of choice is autologous vein. The question remains whether prosthetic material is a reasonable alternative for limb salvage, if autologous vein is not available. From 1991 to 1998, 83 consecutive femorotibial bypass procedures were performed in 70 patients. Thin-walled, ringed 6-mm polytetrafluoroethylene (PTFE) was used, as autologous vein was not available. The indication for the femorotibial bypass was critical ischemia due to atherosclerotic occlusive disease in all cases. Three patients died in the hospital or within 30 days of the operation, resulting in a perioperative mortality rate of 3.6%. After 5 years, 33 patients had died (40%) and 3 patients were lost to follow-up (3.6%). Primary patency was 64.2% after 6 weeks and 18% +/- 5% after 5 years. Secondary patency was 74.1% after 6 weeks and 22.3% +/- 6% after 5 years. When we compared primary and secondary patency for distal anastomosis, there was no difference between the three crural arteries. The limb salvage rate was 61.9% +/- 7% after 5 years. From these results we conclude that, with a limb salvage of 61.9%, PTFE is an acceptable alternative for a femorotibial bypass graft in patients with critical ischemia, if autologous vein is not available.
对于股胫动脉搭桥移植术,首选的材料是自体静脉。如果没有自体静脉,人工血管材料是否是挽救肢体的合理替代方案仍是个问题。1991年至1998年,连续对70例患者进行了83例股胫动脉搭桥手术。由于没有自体静脉,使用了薄壁、带环的6毫米聚四氟乙烯(PTFE)。所有病例中股胫动脉搭桥的指征均为动脉粥样硬化闭塞性疾病导致的严重缺血。3例患者在医院内或术后30天内死亡,围手术期死亡率为3.6%。5年后,33例患者死亡(40%),3例患者失访(3.6%)。6周时的原发性通畅率为64.2%,5年后为18%±5%。6周时的继发性通畅率为74.1%,5年后为22.3%±6%。当我们比较远端吻合的原发性和继发性通畅率时,三条小腿动脉之间没有差异。5年后的肢体挽救率为61.9%±7%。从这些结果我们得出结论,对于严重缺血且没有自体静脉的患者,PTFE作为股胫动脉搭桥移植的替代材料,肢体挽救率为61.9%,是可以接受的。